Inspira Technologies Oxy B.H.N. (IINN)
Builds AME quantum-connectivity hardware while advancing respiratory support and blood-monitoring devices.
$1.05
At close−0.01 (−0.94%)
In millions of USD, except per-share figures
| In millions | Q1 FY22Mar 2022 | Q2 FY22Jun 2022 | Q3 FY22Sep 2022 | Q4 FY22Dec 2022 | Q1 FY23Mar 2023 | Q2 FY23Jun 2023 | Q3 FY23Sep 2023 | Q4 FY23Dec 2023 | Q1 FY24Mar 2024 | Q2 FY24Jun 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | −5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross profit | 0 | 0 | 0 | −5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 4 | 4 | 4 | 3 | 3 | 3 | 3 | 3 | −3 | −3 | −4 | −4 | |
| Research & development | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| 2 | 2 | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | |
| Selling & marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & administrative | 2 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
| Other expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | −6 | −6 | −7 | −7 |
| Operating income | 1 | −4 | −4 | −3 | −3 | −3 | −3 | −3 | 3 | 3 | 4 | 4 |
| 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | −6 | −6 | −7 | −7 | |
| Interest income | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other non-operating income | 0 | −2 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 6 | 7 | 7 |
| Income before tax | −1 | −2 | −4 | −3 | −3 | −3 | −2 | −3 | −3 | −3 | −3 | −3 |
| Net income from continuing operations | −1 | −2 | −4 | −3 | −3 | −3 | −2 | −3 | −3 | −3 | −3 | −3 |
| Net income | 3 | 3 | −4 | −3 | −3 | −3 | −2 | −3 | −3 | −3 | −3 | −3 |
| EPS, basic | $0.28 | $0.24 | −$0.34 | −$0.28 | −$0.23 | −$0.24 | −$0.21 | −$0.19 | −$0.19 | −$0.19 | −$0.12 | −$0.12 |
| EPS, diluted | $0.28 | $0.23 | −$0.33 | −$0.28 | −$0.23 | −$0.24 | −$0.21 | −$0.19 | −$0.19 | −$0.19 | −$0.12 | −$0.12 |
| Weighted average shares, basic | 11 | 11 | 11 | 11 | 12 | 12 | 12 | 16 | 17 | 17 | 27 | 27 |
| Weighted average shares, diluted | 11 | 11 | 11 | 11 | 12 | 12 | 12 | 16 | 17 | 17 | 27 | 27 |
| EBITDA | −4 | −2 | −4 | −3 | −3 | −3 | −2 | −3 | −3 | −3 | −4 | −4 |
| Depreciation & amortization | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EBIT | −4 | −2 | −4 | −3 | −3 | −3 | −2 | −3 | −3 | −3 | −4 | −4 |
